Azzad Asset Management’s AngioDynamics ANGO Stock Holding History

Azzad Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,544	Closed	-$241K	–	314
2022 Q3	$241K	Sell	23,544 -22	-0.1%	-$483	0.02%	386
2022 Q2	$241K	Buy	+23,566	New	+$483K	0.02%	379
2020 Q3	–	Sell	-23,391	Closed	-$238K	–	291
2020 Q2	$238K	Buy	23,391 +322	+1%	+$3.32K	0.06%	282
2020 Q1	$241K	Sell	23,069 -23,071	-50%	-$290K	0.07%	288
2019 Q4	$602K	Sell	46,140 -634	-1%	-$9.68K	0.07%	288
2019 Q3	$669K	Buy	46,774 +22,991	+97%	+$450K	0.08%	277
2019 Q2	$468K	Buy	23,783 +1,405	+6%	+$28.6K	0.13%	237
2019 Q1	$512K	Buy	22,378 +9,634	+76%	+$209K	0.15%	221
2018 Q4	$257K	Sell	12,744 -25	-0.2%	-$517	0.09%	281
2018 Q3	$278K	Buy	+12,769	New	+$284K	0.07%	306

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Azzad Asset Management's ANGO Position: Q4 2022 in Review

Azzad Asset Management sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 23,544 shares — an estimated $241K sold.

Azzad Asset Management first reported a position in ANGO in Q3 2018 and held it in 10 quarters. The position peaked at $669K in Q3 2019. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.

Azzad Asset Management reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
Azzad Asset Management sold 23,544 AngioDynamics shares in Q4 2022, an estimated $241K.
Azzad Asset Management first reported a position in AngioDynamics in Q3 2018 and held it in 10 quarters.
Azzad Asset Management's AngioDynamics position peaked at $669K in Q3 2019.
149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.

Based on Azzad Asset Management's 13F filing for Q4 2022, filed 1 Apr 2024.